Pyrido[2,3-b][1,4]oxazines or tetrahydropyrido[2,3-b][1,4]oxazepines as IAP antagonists
US-12583866-B2 · Mar 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Beone Medicines I Gmbh patents
Beone Medicines I Gmbh holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 4 |
| First publication | Oct 28, 2025 |
| Latest publication | Mar 24, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Bcl-2 inhibitors
US-12516053-B2 · Jan 6, 2026 · US
Tricyclic compounds as HPK1 inhibitor and the use thereof
US-12459958-B2 · Nov 4, 2025 · US
Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof
US-12454534-B2 · Oct 28, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Pyrido[2,3-b][1,4]oxazines or tetrahydropyrido[2,3-b][1,4]oxazepines as IAP antagonists
US-12583866-B2 · Mar 24, 2026 · US
Bcl-2 inhibitors
US-12516053-B2 · Jan 6, 2026 · US
Tricyclic compounds as HPK1 inhibitor and the use thereof
US-12459958-B2 · Nov 4, 2025 · US
Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof
US-12454534-B2 · Oct 28, 2025 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |